Tyrosine phosphorylation of the κ-opioid receptor regulates agonist efficacy

被引:14
作者
Appleyard, SM
McLaughlin, JP
Chavkin, C
机构
[1] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA
[2] Univ Washington, Neurobiol Program, Seattle, WA 98195 USA
关键词
D O I
10.1074/jbc.M006756200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To explore the role of highly conserved tyrosine residues in the putative cytoplasmic domains of the seven transmembrane G protein coupled opioid receptors, we expressed the rat kappa -opioid receptor (KOR) in Xenopus oocytes and then activated the intrinsic insulin receptor tyrosine kinase, KOR activation by the agonist U69593 produced a strong increase in potassium current through coexpressed G protein-gated inwardly rectifying potassium channels (K(IR)3), Brief pretreatment with insulin caused a 60% potentiation of the KOR-activated response. The insulin-induced increase in kappa -opioid response was blocked by the tyrosine kinase inhibitor genistein. In contrast, insulin had no effect on the basal activity of K(IR)3, suggesting that KOR is the target of the tyrosine kinase cascade. Mutation of tyrosine residues to phenylalanines in either the first or second intracellular loop of KOR to produce KOR(Y87F) and KOR(Y157F) had no effect on either the potency or maximal effect of U69593, However, neither KOR(Y87F)- nor KOR(Y157F)-mediated responses were potentiated by insulin treatment. Insulin pretreatment shifted the dose-response curve for U69593 activation of KOR by increasing the maximal response without changing the EC50 value for U69593. These results suggest that insulin increases the efficacy of KOR activation by phosphorylating two tyrosine residues in the first and second intracellular loops of the receptor. Thus, tyrosine phosphorylation may provide an important mechanism for modulation of G protein-coupled receptor signaling.
引用
收藏
页码:38281 / 38285
页数:5
相关论文
共 27 条
[11]   Insulin stimulates sequestration of β-adrenergic receptors and enhanced association of β-adrenergic receptors with Grb2 via tyrosine 350 [J].
Karoor, V ;
Wang, L ;
Wang, HY ;
Malbon, CC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (49) :33035-33041
[12]   Allelic variation S268P of the human μ-opioid receptor affects both desensitization and G protein coupling [J].
Koch, T ;
Kroslak, T ;
Averbeck, M ;
Mayer, P ;
Schröder, H ;
Raulf, E ;
Höllt, V .
MOLECULAR PHARMACOLOGY, 2000, 58 (02) :328-334
[13]  
Koch T, 1997, J NEUROCHEM, V69, P1767
[14]   Molecular mechanisms and regulation of opioid receptor signaling [J].
Law, PY ;
Wong, YH ;
Loh, HH .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2000, 40 :389-430
[15]  
LEONARD JP, 1991, MOL NEUROBIOLOGY PRA, P161
[16]   Physiological regulation of G protein-linked signaling [J].
Morris, AJ ;
Malbon, CC .
PHYSIOLOGICAL REVIEWS, 1999, 79 (04) :1373-1430
[17]   Insulin signalling: Metabolic pathways and mechanisms for specificity [J].
Nystrom, FH ;
Quon, MJ .
CELLULAR SIGNALLING, 1999, 11 (08) :563-574
[18]   Endogenous opiates: 1997 [J].
Olson, GA ;
Olson, RD ;
Vaccarino, AL ;
Kastin, AJ .
PEPTIDES, 1998, 19 (10) :1791-1843
[19]   Agonist-induced, G protein-dependent and -independent down-regulation of the μ opioid receptor -: The receptor is a direct substrate for protein-tyrosine kinase [J].
Pak, Y ;
O'Dowd, BF ;
Wang, JB ;
George, SR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (39) :27610-27616
[20]   A mitogen-activated protein kinase pathway is required for μ-opioid receptor desensitization [J].
Polakiewicz, RD ;
Schieferl, SM ;
Dorner, LF ;
Kansra, V ;
Comb, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (20) :12402-12406